Linifanib, CAS [[796967-16-3]]

Produktübersicht

• Artikelname: Linifanib, CAS [[796967-16-3]]
• Artikelnummer: TGM-T2514
• Hersteller Artikelnummer: T2514
• Alternativnummer: TGM-T2514-1MLX10MM(INDMSO),TGM-T2514-5MG,TGM-T2514-10MG,TGM-T2514-25MG,TGM-T2514-50MG,TGM-T2514-100MG,TGM-T2514-200MG,TGM-T2514-500MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: ABT-869 , RG3635 , AL-39324

Produktbeschreibung

Linifanib (AL-39324) (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR (IC50: 4 nM), CSF-1R (IC50: 3 nM), Flt-1/3 (IC50: 3/4 nM) and PDGFRbeta (IC50: 66 nM). Linifanib may exhibit potent antiproliferative and apoptotic effects on tumor cells whose proliferation is dependent on mutant kinases, such as FMS-related tyrosine kinase receptor-3 (FLT3).

Produkteigenschaften

• Molekulargewicht: 375.4
• Reinheit: 98.00%
• CAS Nummer: [796967-16-3]
• Formel: C21H18FN5O
• Target-Kategorie: Apoptosis|||VEGFR|||FLT|||c-Fms|||CSF-1R|||Autophagy|||PDGFR|||c-Kit

Bilder

T2514